Navigation Links
Haemonetics Reports Third Quarter of Fiscal 11
Date:1/31/2011

s186,054170,1739.3%Operating income 81,65479,1843.1%Interest income/(expense), net400(413)(196.9%)Other expense, net(544)(1,389)(60.9%)Income before taxes81,51077,3825.3%Tax expense22,51822,973(2.0%)NET INCOME$58,992$54,4098.4%Net income per common shareassuming dilution $2.32$2.0811.2%Weighted average number of sharesBasic24,93325,544Diluted25,47726,150Profit Margins:Inc/(Dec) vs
prior year profit
margin % Gross profit52.8%52.4%0.4%R&D4.7%4.1%0.6%S,G&A32.4%31.6%0.8%Operating income16.1%16.6%(0.5%)Income before taxes16.1%16.2%(0.1%)Net income11.6%11.4%0.2%Revenue Analysis for the Third Quarter and Year-To-Date FY11 and FY10Third Quarter1/1/2011
As Reported12/26/2009
As Reported% Inc/(Dec) vs
Prior YearRevenues by geographyUnited States

$79,844$74,9976.5%International

$96,945$90,1727.5%Net revenues

$176,789$165,1697.0%Disposable revenuesPlasma disposables

$59,814$59,1771.1%Blood bank disposablesPlatelet

$41,057$39,7933.2%Red cell

$11,676$12,022(2.9%)$52,732$51,8151.8%Hospital disposablesSurgical

$17,117$17,864(4.2%)OrthoPAT

$9,248$9,864(6.2%)Diagnostics

$5,220$4,33120.5%$31,584$32,059(1.5%)Subtotal

$144,130$143,0510.8%Software solutions

$16,571$8,256100.7%Equipment & other

$16,088$13,86216.1%Net revenues

$176,789$165,1697.0%Nine Months Ended1/1/2011
As Reported12/26/2009
As Reported% Inc/(Dec) vs
Prior YearRevenues by geographyUnited States

$237,893$225,2235.6%International

$268,768$251,1037.0%Net revenues

$506,661$476,3266.4%Disposable revenuesPlasma disposables

$172,245$177,469(2.9%)Blood bank disposablesPlatelet

$117,120$111,3505.2%Red cell

$34,284$
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Haemonetics Receives Favorable Ruling in Patent Lawsuit against Competitive Technology
2. Neogen Reports 33% Increase in Net Income
3. Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
4. New Topical Patent Research Reports Recently Published at MarketPublishers.com
5. YM BioSciences Reports Positive Interim Data Including Substantial Anemia Response from Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387
6. Oncothyreon Reports Positive Data from Phase 1 Clinical Trial of PI3-Kinase Inhibitor PX-866 in Patients with Relapsed or Refractory Solid Tumors
7. GeneLink Reports Third Quarter Results
8. Imagenetix, Inc. Reports Second Quarter 2011 Results
9. Transgenomic Reports Third Quarter Financial Results
10. Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... ... August 26, 2015 , ... Lee Biosolutions, a ... development and manufacture of highly valued cardiac markers used in early detection of ... with protein chemistry has led to the development and commercialization of important cardiac ...
(Date:8/26/2015)... 26, 2015 Israel Proves Its Place in ... st place  Wayerz comes in 5 th ... by venture capital fund JVP, with Chinese consulting firm ... China , Israel , ... Impressive achievement for the Israeli representatives in the final round ...
(Date:8/26/2015)... (PRWEB) , ... August 26, 2015 , ... PRC ... to develop new business relationships with local sponsors in southern California. The Clinical Trial ... their drug development processes and regulatory pathways., , Stem ...
(Date:8/25/2015)... ... August 25, 2015 , ... Vets ... in Knapp, Wis. The company has added a AS16 Sharples centrifuge to harvest ... collection during bacterial or fungal fermentation process development. , The new centrifuge ...
Breaking Biology Technology:Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3New centrifuge and fermentor expand product development capacity at Vets Plus 2
... July 19, 2011 COPAN will be holding a ... Annual Meeting. The workshop will be held at the ... AM. This program is approved for 1.5 ACCENT® Continuing ... charge and open to AACC attendees ( http://conta.cc/jI0TSV ). ...
... 19, 2011 , Convergence Pharmaceuticals Limited ... high value analgesic,medicines, today announces that the Phase II ... with lumbosacral,radiculopathy (LSR) has started. LSR is ... nerve roots in the lumbar region of the spine. ...
... from cadmium and selenium degrade in soil, unleashing toxic ... at Buffalo study has found. The research, accepted ... Technology , demonstrates the importance of learning more about ... with the environment after disposal, said Diana Aga, the ...
Cached Biology Technology:COPAN Announces Workshop on Automated Specimen Processing, Digital Workup and Reporting in Microbiology During AACC Clinical Lab Expo 2Convergence Pharmaceuticals Announces Start of Phase II Study for its Selective Nav 1.7 blocker CNV1014802 2Convergence Pharmaceuticals Announces Start of Phase II Study for its Selective Nav 1.7 blocker CNV1014802 3Convergence Pharmaceuticals Announces Start of Phase II Study for its Selective Nav 1.7 blocker CNV1014802 4Cadmium selenide quantum dots degrade in soil, releasing their toxic guts, study finds 2Cadmium selenide quantum dots degrade in soil, releasing their toxic guts, study finds 3
(Date:8/10/2015)... , August 10, 2015 ... Eye Tracking Technology for more than two decades, announces ... for integration into all consumer display formats. The SMI ... integration of eye tracking into consumer tablets, laptops, desktop ... smart glasses. Omnivision,s leading sensor technology contributes to the ...
(Date:8/6/2015)... REDWOOD CITY, Calif. , Aug. 6, 2015 ... (D-Silicon Valley) will visit Crossmatch ™ to ... secure networks and protect data. Crossmatch is a ... solutions whose technologies and expertise are helping federal ... operational efficiency and security.   "The ...
(Date:8/6/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced collaboration with Microsoft on biometric fingerprint ... leveraged Synaptics, deep expertise in human interface which ... Through stringent testing, Synaptics, advanced image sensing ... Precision TouchPad (PTP) specification empowering OEMs with Windows ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Rep. Honda to Visit Crossmatch in Redwood City 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... for sleeping sickness, carried out by the international humanitarian ... research arm, Epicentre, have now been published in the ... sickness affects many tens of thousands of people each ... for which there are few treatment options. The most commonly ...
... are releasing methane, a greenhouse gas, at rates that appear ... acting as a positive feedback to climate warming, said Katey ... , Walter's project is the first time this type of ... estimates were missing a very large and important component of ...
... As part of the international Census of Marine Life ... on an expedition to explore coral reef biodiversity in ... Northwestern Hawaiian Islands Marine National Monument. Led by ... Fisheries Science Center, with funding from NOAA's Coral Reef ...
Cached Biology News:Siberian lakes burp 'time-bomb' greenhouse gas 2First Biodiversity Census of coral reef ecosystems in the NW Hawaiian Islands 2First Biodiversity Census of coral reef ecosystems in the NW Hawaiian Islands 3
Rat CNTF R alpha Affinity Purified Polyclonal Ab...
Human MFRP MAb (Clone 291218)...
Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab...
... NOS activity by monitoring the conversion of ... simple, sensitive, and specific for NOS activity ... and purified enzyme preparations. The kit includes ... reactions. Radiolabeled arginine and NADPH are not ...
Biology Products: